nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—Dacarbazine—sarcoma	0.124	0.276	CbGbCtD
Fingolimod—CYP2E1—Mitoxantrone—sarcoma	0.0964	0.214	CbGbCtD
Fingolimod—CYP3A4—Thiotepa—sarcoma	0.068	0.151	CbGbCtD
Fingolimod—CYP2E1—Etoposide—sarcoma	0.0608	0.135	CbGbCtD
Fingolimod—CYP3A4—Mitoxantrone—sarcoma	0.0292	0.065	CbGbCtD
Fingolimod—S1PR1—umbilical vein—sarcoma	0.021	0.0896	CbGeAlD
Fingolimod—CYP3A4—Vincristine—sarcoma	0.0201	0.0447	CbGbCtD
Fingolimod—CYP2D6—Doxorubicin—sarcoma	0.0198	0.044	CbGbCtD
Fingolimod—CYP3A4—Etoposide—sarcoma	0.0184	0.041	CbGbCtD
Fingolimod—CYP3A4—Doxorubicin—sarcoma	0.0126	0.028	CbGbCtD
Fingolimod—S1PR5—mammary gland—sarcoma	0.0109	0.0467	CbGeAlD
Fingolimod—S1PR1—endothelium—sarcoma	0.00994	0.0425	CbGeAlD
Fingolimod—S1PR1—mammary gland—sarcoma	0.00801	0.0342	CbGeAlD
Fingolimod—S1PR4—hematopoietic system—sarcoma	0.00793	0.0339	CbGeAlD
Fingolimod—SPHK1—mammary gland—sarcoma	0.00793	0.0339	CbGeAlD
Fingolimod—S1PR5—hematopoietic system—sarcoma	0.00667	0.0285	CbGeAlD
Fingolimod—CYP4F2—hematopoietic system—sarcoma	0.00625	0.0267	CbGeAlD
Fingolimod—S1PR5—skin of body—sarcoma	0.00579	0.0247	CbGeAlD
Fingolimod—SPHK1—myometrium—sarcoma	0.00563	0.024	CbGeAlD
Fingolimod—S1PR4—lymphoid tissue—sarcoma	0.00558	0.0238	CbGeAlD
Fingolimod—S1PR3—hematopoietic system—sarcoma	0.00554	0.0236	CbGeAlD
Fingolimod—CYP4F12—myometrium—sarcoma	0.00541	0.0231	CbGeAlD
Fingolimod—S1PR4—bone marrow—sarcoma	0.00509	0.0217	CbGeAlD
Fingolimod—CYP4F12—seminal vesicle—sarcoma	0.00488	0.0209	CbGeAlD
Fingolimod—S1PR1—hematopoietic system—sarcoma	0.00488	0.0208	CbGeAlD
Fingolimod—S1PR3—smooth muscle tissue—sarcoma	0.00488	0.0208	CbGeAlD
Fingolimod—SPHK1—hematopoietic system—sarcoma	0.00483	0.0206	CbGeAlD
Fingolimod—S1PR1—connective tissue—sarcoma	0.0047	0.0201	CbGeAlD
Fingolimod—S1PR5—lymphoid tissue—sarcoma	0.00469	0.02	CbGeAlD
Fingolimod—S1PR1—smooth muscle tissue—sarcoma	0.0043	0.0184	CbGeAlD
Fingolimod—SPHK1—smooth muscle tissue—sarcoma	0.00426	0.0182	CbGeAlD
Fingolimod—S1PR3—cardiac atrium—sarcoma	0.00421	0.018	CbGeAlD
Fingolimod—SPHK1—skin of body—sarcoma	0.0042	0.0179	CbGeAlD
Fingolimod—CYP4F2—bone marrow—sarcoma	0.004	0.0171	CbGeAlD
Fingolimod—Non-Hodgkin's lymphoma—Mitoxantrone—sarcoma	0.00394	0.0358	CcSEcCtD
Fingolimod—S1PR3—lymphoid tissue—sarcoma	0.0039	0.0166	CbGeAlD
Fingolimod—S1PR3—tendon—sarcoma	0.00367	0.0157	CbGeAlD
Fingolimod—SPHK1—uterus—sarcoma	0.00365	0.0156	CbGeAlD
Fingolimod—CYP4F12—cardiac atrium—sarcoma	0.00352	0.015	CbGeAlD
Fingolimod—CYP4F12—uterus—sarcoma	0.00351	0.015	CbGeAlD
Fingolimod—S1PR5—liver—sarcoma	0.00345	0.0147	CbGeAlD
Fingolimod—S1PR1—lymphoid tissue—sarcoma	0.00344	0.0147	CbGeAlD
Fingolimod—CYP4F2—liver—sarcoma	0.00324	0.0138	CbGeAlD
Fingolimod—SPHK1—tendon—sarcoma	0.0032	0.0137	CbGeAlD
Fingolimod—S1PR4—lymph node—sarcoma	0.00315	0.0135	CbGeAlD
Fingolimod—S1PR3—testis—sarcoma	0.00304	0.013	CbGeAlD
Fingolimod—CYP4F12—bone marrow—sarcoma	0.00298	0.0127	CbGeAlD
Fingolimod—Cerebral haemorrhage—Thiotepa—sarcoma	0.00288	0.0261	CcSEcCtD
Fingolimod—S1PR3—liver—sarcoma	0.00287	0.0123	CbGeAlD
Fingolimod—S1PR1—testis—sarcoma	0.00268	0.0114	CbGeAlD
Fingolimod—SPHK1—testis—sarcoma	0.00265	0.0113	CbGeAlD
Fingolimod—S1PR5—lymph node—sarcoma	0.00265	0.0113	CbGeAlD
Fingolimod—S1PR3—S1P3 pathway—VEGFA—sarcoma	0.00258	0.0125	CbGpPWpGaD
Fingolimod—Cerebral haemorrhage—Vincristine—sarcoma	0.00255	0.0232	CcSEcCtD
Fingolimod—CYP4F12—testis—sarcoma	0.00254	0.0109	CbGeAlD
Fingolimod—S1PR1—liver—sarcoma	0.00253	0.0108	CbGeAlD
Fingolimod—SPHK1—Beta3 integrin cell surface interactions—KDR—sarcoma	0.00244	0.0118	CbGpPWpGaD
Fingolimod—CYP4F12—liver—sarcoma	0.0024	0.0103	CbGeAlD
Fingolimod—SPHK1—Signaling by VEGF—VEGFC—sarcoma	0.0024	0.0117	CbGpPWpGaD
Fingolimod—CYP4F12—Tryptophan metabolism—MDM2—sarcoma	0.00226	0.011	CbGpPWpGaD
Fingolimod—S1PR3—lymph node—sarcoma	0.0022	0.00939	CbGeAlD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—PLCG1—sarcoma	0.002	0.00971	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—PLCG1—sarcoma	0.002	0.00969	CbGpPWpGaD
Fingolimod—S1PR1—lymph node—sarcoma	0.00194	0.00828	CbGeAlD
Fingolimod—Gamma-glutamyltransferase increased—Thiotepa—sarcoma	0.00194	0.0176	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—FLT1—sarcoma	0.00192	0.00933	CbGpPWpGaD
Fingolimod—SPHK1—lymph node—sarcoma	0.00192	0.00819	CbGeAlD
Fingolimod—SPHK1—Signaling by VEGF—PLCG1—sarcoma	0.00189	0.00917	CbGpPWpGaD
Fingolimod—CYP4F12—lymph node—sarcoma	0.00184	0.00787	CbGeAlD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—PLCG1—sarcoma	0.00177	0.00858	CbGpPWpGaD
Fingolimod—Gamma-glutamyltransferase increased—Mitoxantrone—sarcoma	0.00167	0.0152	CcSEcCtD
Fingolimod—SPHK1—VEGFR2 mediated cell proliferation—SRC—sarcoma	0.00166	0.00807	CbGpPWpGaD
Fingolimod—SPHK1—VEGFR2 mediated cell proliferation—VEGFA—sarcoma	0.00162	0.00786	CbGpPWpGaD
Fingolimod—SPHK1—VEGFR2 mediated cell proliferation—NRAS—sarcoma	0.0016	0.00776	CbGpPWpGaD
Fingolimod—Hepatic enzyme increased—Mitoxantrone—sarcoma	0.00145	0.0132	CcSEcCtD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—PDGFRB—sarcoma	0.00141	0.00687	CbGpPWpGaD
Fingolimod—SPHK1—VEGFR2 mediated cell proliferation—KRAS—sarcoma	0.00138	0.00668	CbGpPWpGaD
Fingolimod—SPHK1—Beta3 integrin cell surface interactions—VEGFA—sarcoma	0.00134	0.00651	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—CXCR4—sarcoma	0.00132	0.00643	CbGpPWpGaD
Fingolimod—S1PR1—Fc-epsilon receptor I signaling in mast cells—JUN—sarcoma	0.00131	0.00637	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—CXCR4—sarcoma	0.00128	0.00619	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—CXCR4—sarcoma	0.00128	0.00619	CbGpPWpGaD
Fingolimod—Lymphopenia—Epirubicin—sarcoma	0.00125	0.0114	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—PDGFRB—sarcoma	0.00125	0.00608	CbGpPWpGaD
Fingolimod—CYP2E1—Folate-Alcohol and Cancer Pathway—CREB1—sarcoma	0.00123	0.00595	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—KDR—sarcoma	0.00117	0.0057	CbGpPWpGaD
Fingolimod—SPHK1—VEGFR2 mediated cell proliferation—HRAS—sarcoma	0.00117	0.00568	CbGpPWpGaD
Fingolimod—SPHK1—Fc-epsilon receptor I signaling in mast cells—JUN—sarcoma	0.00116	0.00564	CbGpPWpGaD
Fingolimod—Lymphopenia—Doxorubicin—sarcoma	0.00116	0.0105	CcSEcCtD
Fingolimod—S1PR1—G alpha (i) signalling events—CXCR4—sarcoma	0.00116	0.00562	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—KDR—sarcoma	0.00111	0.00538	CbGpPWpGaD
Fingolimod—Cardiac arrest—Thiotepa—sarcoma	0.0011	0.00999	CcSEcCtD
Fingolimod—Liver function test abnormal—Dactinomycin—sarcoma	0.00106	0.00963	CcSEcCtD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00105	0.00511	CbGpPWpGaD
Fingolimod—Aspartate aminotransferase increased—Thiotepa—sarcoma	0.00104	0.00946	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Dactinomycin—sarcoma	0.00103	0.00939	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Thiotepa—sarcoma	0.00102	0.00927	CcSEcCtD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00101	0.00492	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.00101	0.00492	CbGpPWpGaD
Fingolimod—Cardiac arrest—Vincristine—sarcoma	0.000975	0.00886	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Vincristine—sarcoma	0.000923	0.00839	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000921	0.00447	CbGpPWpGaD
Fingolimod—Aspartate aminotransferase increased—Mitoxantrone—sarcoma	0.000899	0.00817	CcSEcCtD
Fingolimod—Pneumonia—Thiotepa—sarcoma	0.000896	0.00814	CcSEcCtD
Fingolimod—Infestation NOS—Thiotepa—sarcoma	0.000891	0.0081	CcSEcCtD
Fingolimod—Infestation—Thiotepa—sarcoma	0.000891	0.0081	CcSEcCtD
Fingolimod—Pneumonia—Dactinomycin—sarcoma	0.000889	0.00808	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Mitoxantrone—sarcoma	0.00088	0.008	CcSEcCtD
Fingolimod—Herpes zoster—Epirubicin—sarcoma	0.000852	0.00774	CcSEcCtD
Fingolimod—S1PR1—Fc-epsilon receptor I signaling in mast cells—HRAS—sarcoma	0.000828	0.00402	CbGpPWpGaD
Fingolimod—CYP2E1—seminal vesicle—sarcoma	0.000824	0.00352	CbGeAlD
Fingolimod—S1PR4—GPCR ligand binding—CXCR4—sarcoma	0.000802	0.00389	CbGpPWpGaD
Fingolimod—Weight decreased—Vincristine—sarcoma	0.000802	0.00729	CcSEcCtD
Fingolimod—Pneumonia—Vincristine—sarcoma	0.000795	0.00722	CcSEcCtD
Fingolimod—Cardiac arrest—Etoposide—sarcoma	0.00079	0.00718	CcSEcCtD
Fingolimod—Herpes zoster—Doxorubicin—sarcoma	0.000788	0.00716	CcSEcCtD
Fingolimod—Depression—Vincristine—sarcoma	0.000788	0.00716	CcSEcCtD
Fingolimod—Connective tissue disorder—Thiotepa—sarcoma	0.000786	0.00714	CcSEcCtD
Fingolimod—CYP2E1—hematopoietic system—sarcoma	0.000783	0.00334	CbGeAlD
Fingolimod—Weight decreased—Mitoxantrone—sarcoma	0.000781	0.0071	CcSEcCtD
Fingolimod—Pneumonia—Mitoxantrone—sarcoma	0.000774	0.00703	CcSEcCtD
Fingolimod—S1PR3—GPCR ligand binding—CXCR4—sarcoma	0.000772	0.00375	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CXCR4—sarcoma	0.000772	0.00375	CbGpPWpGaD
Fingolimod—Liver injury—Epirubicin—sarcoma	0.000762	0.00693	CcSEcCtD
Fingolimod—Eye disorder—Thiotepa—sarcoma	0.000747	0.00679	CcSEcCtD
Fingolimod—Cardiac disorder—Thiotepa—sarcoma	0.000742	0.00675	CcSEcCtD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—JUN—sarcoma	0.000739	0.00359	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—CTNNB1—sarcoma	0.000735	0.00357	CbGpPWpGaD
Fingolimod—SPHK1—Fc-epsilon receptor I signaling in mast cells—HRAS—sarcoma	0.000733	0.00356	CbGpPWpGaD
Fingolimod—Alanine aminotransferase increased—Etoposide—sarcoma	0.000732	0.00666	CcSEcCtD
Fingolimod—Angiopathy—Thiotepa—sarcoma	0.000726	0.00659	CcSEcCtD
Fingolimod—Sinusitis—Mitoxantrone—sarcoma	0.000722	0.00656	CcSEcCtD
Fingolimod—Mediastinal disorder—Thiotepa—sarcoma	0.000721	0.00655	CcSEcCtD
Fingolimod—Alopecia—Thiotepa—sarcoma	0.000707	0.00642	CcSEcCtD
Fingolimod—Liver injury—Doxorubicin—sarcoma	0.000705	0.00641	CcSEcCtD
Fingolimod—Bradycardia—Mitoxantrone—sarcoma	0.000703	0.00639	CcSEcCtD
Fingolimod—Alopecia—Dactinomycin—sarcoma	0.000701	0.00637	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—CXCR4—sarcoma	0.000701	0.0034	CbGpPWpGaD
Fingolimod—Mental disorder—Thiotepa—sarcoma	0.000701	0.00637	CcSEcCtD
Fingolimod—Connective tissue disorder—Vincristine—sarcoma	0.000697	0.00633	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—CTNNB1—sarcoma	0.000694	0.00337	CbGpPWpGaD
Fingolimod—Back pain—Thiotepa—sarcoma	0.000673	0.00612	CcSEcCtD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—SRC—sarcoma	0.000665	0.00323	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—SRC—sarcoma	0.000663	0.00322	CbGpPWpGaD
Fingolimod—Atrioventricular block—Epirubicin—sarcoma	0.000661	0.00601	CcSEcCtD
Fingolimod—Cardiac disorder—Vincristine—sarcoma	0.000658	0.00598	CcSEcCtD
Fingolimod—Vision blurred—Thiotepa—sarcoma	0.000656	0.00596	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—JUN—sarcoma	0.000654	0.00317	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—VEGFA—sarcoma	0.000647	0.00314	CbGpPWpGaD
Fingolimod—Pneumonia—Etoposide—sarcoma	0.000644	0.00585	CcSEcCtD
Fingolimod—Angiopathy—Vincristine—sarcoma	0.000643	0.00585	CcSEcCtD
Fingolimod—Infestation—Etoposide—sarcoma	0.00064	0.00582	CcSEcCtD
Fingolimod—Infestation NOS—Etoposide—sarcoma	0.00064	0.00582	CcSEcCtD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—NRAS—sarcoma	0.000639	0.0031	CbGpPWpGaD
Fingolimod—Mediastinal disorder—Vincristine—sarcoma	0.000639	0.00581	CcSEcCtD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—NRAS—sarcoma	0.000638	0.0031	CbGpPWpGaD
Fingolimod—CYP3A4—hematopoietic system—sarcoma	0.00063	0.00269	CbGeAlD
Fingolimod—SPHK1—Signaling by VEGF—SRC—sarcoma	0.000627	0.00304	CbGpPWpGaD
Fingolimod—Alopecia—Vincristine—sarcoma	0.000627	0.0057	CcSEcCtD
Fingolimod—Leukopenia—Thiotepa—sarcoma	0.000623	0.00566	CcSEcCtD
Fingolimod—Mental disorder—Vincristine—sarcoma	0.000621	0.00565	CcSEcCtD
Fingolimod—CYP2D6—hematopoietic system—sarcoma	0.00062	0.00265	CbGeAlD
Fingolimod—Leukopenia—Dactinomycin—sarcoma	0.000618	0.00562	CcSEcCtD
Fingolimod—Atrioventricular block—Doxorubicin—sarcoma	0.000612	0.00556	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—VEGFA—sarcoma	0.000611	0.00296	CbGpPWpGaD
Fingolimod—Alopecia—Mitoxantrone—sarcoma	0.00061	0.00555	CcSEcCtD
Fingolimod—Cough—Thiotepa—sarcoma	0.000607	0.00552	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—NRAS—sarcoma	0.000603	0.00293	CbGpPWpGaD
Fingolimod—Hypertension—Thiotepa—sarcoma	0.000601	0.00546	CcSEcCtD
Fingolimod—Back pain—Vincristine—sarcoma	0.000597	0.00543	CcSEcCtD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—MYC—sarcoma	0.000594	0.00288	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.000589	0.00535	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—SRC—sarcoma	0.000587	0.00285	CbGpPWpGaD
Fingolimod—Back pain—Mitoxantrone—sarcoma	0.000582	0.00529	CcSEcCtD
Fingolimod—Vision blurred—Mitoxantrone—sarcoma	0.000567	0.00515	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—NRAS—sarcoma	0.000565	0.00274	CbGpPWpGaD
Fingolimod—Infection—Thiotepa—sarcoma	0.000564	0.00513	CcSEcCtD
Fingolimod—Infection—Dactinomycin—sarcoma	0.00056	0.00509	CcSEcCtD
Fingolimod—Nervous system disorder—Thiotepa—sarcoma	0.000557	0.00506	CcSEcCtD
Fingolimod—Leukopenia—Vincristine—sarcoma	0.000553	0.00502	CcSEcCtD
Fingolimod—Skin disorder—Thiotepa—sarcoma	0.000552	0.00502	CcSEcCtD
Fingolimod—CYP2E1—lymphoid tissue—sarcoma	0.000551	0.00235	CbGeAlD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—KRAS—sarcoma	0.00055	0.00267	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—KRAS—sarcoma	0.000549	0.00266	CbGpPWpGaD
Fingolimod—Leukopenia—Mitoxantrone—sarcoma	0.000538	0.00489	CcSEcCtD
Fingolimod—Eye disorder—Etoposide—sarcoma	0.000537	0.00488	CcSEcCtD
Fingolimod—Cardiac disorder—Etoposide—sarcoma	0.000533	0.00485	CcSEcCtD
Fingolimod—Hypertension—Vincristine—sarcoma	0.000533	0.00484	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—MYC—sarcoma	0.000526	0.00255	CbGpPWpGaD
Fingolimod—Cough—Mitoxantrone—sarcoma	0.000525	0.00477	CcSEcCtD
Fingolimod—Angiopathy—Etoposide—sarcoma	0.000521	0.00474	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—KRAS—sarcoma	0.000519	0.00252	CbGpPWpGaD
Fingolimod—Hypertension—Mitoxantrone—sarcoma	0.000519	0.00472	CcSEcCtD
Fingolimod—CYP2E1—tendon—sarcoma	0.000518	0.00221	CbGeAlD
Fingolimod—Eczema—Epirubicin—sarcoma	0.000518	0.00471	CcSEcCtD
Fingolimod—Mediastinal disorder—Etoposide—sarcoma	0.000518	0.00471	CcSEcCtD
Fingolimod—Eye pain—Epirubicin—sarcoma	0.000516	0.00469	CcSEcCtD
Fingolimod—Paraesthesia—Thiotepa—sarcoma	0.00051	0.00464	CcSEcCtD
Fingolimod—Alopecia—Etoposide—sarcoma	0.000508	0.00461	CcSEcCtD
Fingolimod—Infection—Vincristine—sarcoma	0.000501	0.00455	CcSEcCtD
Fingolimod—Nervous system disorder—Vincristine—sarcoma	0.000494	0.00449	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Thiotepa—sarcoma	0.00049	0.00446	CcSEcCtD
Fingolimod—Fatigue—Thiotepa—sarcoma	0.00049	0.00445	CcSEcCtD
Fingolimod—Infection—Mitoxantrone—sarcoma	0.000487	0.00443	CcSEcCtD
Fingolimod—Fatigue—Dactinomycin—sarcoma	0.000486	0.00442	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—KRAS—sarcoma	0.000486	0.00236	CbGpPWpGaD
Fingolimod—Back pain—Etoposide—sarcoma	0.000484	0.0044	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—sarcoma	0.000479	0.00436	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—sarcoma	0.000477	0.00434	CcSEcCtD
Fingolimod—Skin disorder—Mitoxantrone—sarcoma	0.000477	0.00433	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—sarcoma	0.000475	0.00432	CcSEcCtD
Fingolimod—Hypotension—Vincristine—sarcoma	0.000471	0.00428	CcSEcCtD
Fingolimod—CYP2D6—Melatonin metabolism and effects—FOXO1—sarcoma	0.00047	0.00228	CbGpPWpGaD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—HRAS—sarcoma	0.000468	0.00227	CbGpPWpGaD
Fingolimod—S1PR1—PDGFR-beta signaling pathway—HRAS—sarcoma	0.000467	0.00226	CbGpPWpGaD
Fingolimod—Hypotension—Mitoxantrone—sarcoma	0.000458	0.00417	CcSEcCtD
Fingolimod—Migraine—Epirubicin—sarcoma	0.000458	0.00416	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—CXCR4—sarcoma	0.000453	0.0022	CbGpPWpGaD
Fingolimod—Paraesthesia—Vincristine—sarcoma	0.000452	0.00411	CcSEcCtD
Fingolimod—Leukopenia—Etoposide—sarcoma	0.000448	0.00407	CcSEcCtD
Fingolimod—Cardiac arrest—Epirubicin—sarcoma	0.000443	0.00402	CcSEcCtD
Fingolimod—SPHK1—Signaling by VEGF—HRAS—sarcoma	0.000441	0.00214	CbGpPWpGaD
Fingolimod—Paraesthesia—Mitoxantrone—sarcoma	0.000441	0.004	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—sarcoma	0.000439	0.00399	CcSEcCtD
Fingolimod—Dyspnoea—Mitoxantrone—sarcoma	0.000437	0.00398	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—CXCR4—sarcoma	0.000436	0.00212	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCR4—sarcoma	0.000436	0.00212	CbGpPWpGaD
Fingolimod—Cough—Etoposide—sarcoma	0.000436	0.00397	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Vincristine—sarcoma	0.000435	0.00395	CcSEcCtD
Fingolimod—Fatigue—Vincristine—sarcoma	0.000434	0.00395	CcSEcCtD
Fingolimod—Hypertension—Etoposide—sarcoma	0.000432	0.00392	CcSEcCtD
Fingolimod—Liver function test abnormal—Epirubicin—sarcoma	0.00043	0.00391	CcSEcCtD
Fingolimod—CYP2E1—testis—sarcoma	0.000429	0.00183	CbGeAlD
Fingolimod—Migraine—Doxorubicin—sarcoma	0.000424	0.00385	CcSEcCtD
Fingolimod—Fatigue—Mitoxantrone—sarcoma	0.000423	0.00384	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000423	0.00384	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000419	0.00381	CcSEcCtD
Fingolimod—SPHK1—PDGFR-beta signaling pathway—HRAS—sarcoma	0.000413	0.002	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CXCR4—sarcoma	0.000412	0.002	CbGpPWpGaD
Fingolimod—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000411	0.00373	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—sarcoma	0.00041	0.00372	CcSEcCtD
Fingolimod—Asthenia—Thiotepa—sarcoma	0.000408	0.00371	CcSEcCtD
Fingolimod—CYP2E1—liver—sarcoma	0.000406	0.00173	CbGeAlD
Fingolimod—Infection—Etoposide—sarcoma	0.000405	0.00369	CcSEcCtD
Fingolimod—Asthenia—Dactinomycin—sarcoma	0.000405	0.00368	CcSEcCtD
Fingolimod—Influenza—Epirubicin—sarcoma	0.000402	0.00366	CcSEcCtD
Fingolimod—Pruritus—Thiotepa—sarcoma	0.000402	0.00365	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—sarcoma	0.000398	0.00361	CcSEcCtD
Fingolimod—Skin disorder—Etoposide—sarcoma	0.000396	0.0036	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—CXCR4—sarcoma	0.000396	0.00192	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCR4—sarcoma	0.000396	0.00192	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCR4—sarcoma	0.000396	0.00192	CbGpPWpGaD
Fingolimod—Diarrhoea—Thiotepa—sarcoma	0.000389	0.00353	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000388	0.00353	CcSEcCtD
Fingolimod—Bronchitis—Epirubicin—sarcoma	0.000387	0.00352	CcSEcCtD
Fingolimod—Diarrhoea—Dactinomycin—sarcoma	0.000386	0.00351	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—TLE1—sarcoma	0.000382	0.00185	CbGpPWpGaD
Fingolimod—Hypotension—Etoposide—sarcoma	0.000381	0.00347	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00038	0.00345	CcSEcCtD
Fingolimod—Dizziness—Thiotepa—sarcoma	0.000376	0.00341	CcSEcCtD
Fingolimod—Influenza—Doxorubicin—sarcoma	0.000372	0.00338	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—ENO2—sarcoma	0.000372	0.00181	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—HBA1—sarcoma	0.00037	0.00179	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TLE1—sarcoma	0.000368	0.00178	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TLE1—sarcoma	0.000368	0.00178	CbGpPWpGaD
Fingolimod—Paraesthesia—Etoposide—sarcoma	0.000366	0.00333	CcSEcCtD
Fingolimod—Weight decreased—Epirubicin—sarcoma	0.000364	0.00331	CcSEcCtD
Fingolimod—Dyspnoea—Etoposide—sarcoma	0.000364	0.00331	CcSEcCtD
Fingolimod—Asthenia—Vincristine—sarcoma	0.000361	0.00329	CcSEcCtD
Fingolimod—Pneumonia—Epirubicin—sarcoma	0.000361	0.00328	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CXCR4—sarcoma	0.00036	0.00175	CbGpPWpGaD
Fingolimod—Infestation NOS—Epirubicin—sarcoma	0.000359	0.00326	CcSEcCtD
Fingolimod—Infestation—Epirubicin—sarcoma	0.000359	0.00326	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—sarcoma	0.000358	0.00325	CcSEcCtD
Fingolimod—Headache—Thiotepa—sarcoma	0.000356	0.00324	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Etoposide—sarcoma	0.000352	0.0032	CcSEcCtD
Fingolimod—Asthenia—Mitoxantrone—sarcoma	0.000352	0.0032	CcSEcCtD
Fingolimod—Fatigue—Etoposide—sarcoma	0.000352	0.0032	CcSEcCtD
Fingolimod—Diarrhoea—Vincristine—sarcoma	0.000345	0.00313	CcSEcCtD
Fingolimod—CYP2D6—testis—sarcoma	0.00034	0.00145	CbGeAlD
Fingolimod—Weight decreased—Doxorubicin—sarcoma	0.000337	0.00306	CcSEcCtD
Fingolimod—Sinusitis—Epirubicin—sarcoma	0.000337	0.00306	CcSEcCtD
Fingolimod—Diarrhoea—Mitoxantrone—sarcoma	0.000336	0.00305	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—sarcoma	0.000334	0.00303	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—TLE1—sarcoma	0.000334	0.00162	CbGpPWpGaD
Fingolimod—Dizziness—Vincristine—sarcoma	0.000333	0.00303	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—sarcoma	0.000332	0.00302	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—sarcoma	0.000332	0.00302	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—sarcoma	0.000328	0.00298	CcSEcCtD
Fingolimod—CYP3A4—liver—sarcoma	0.000326	0.00139	CbGeAlD
Fingolimod—S1PR4—Signaling Pathways—VEGFC—sarcoma	0.000322	0.00156	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ENO2—sarcoma	0.000321	0.00156	CbGpPWpGaD
Fingolimod—CYP2D6—liver—sarcoma	0.000321	0.00137	CbGeAlD
Fingolimod—CYP4F2—Metabolism—HBA1—sarcoma	0.000319	0.00155	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Epirubicin—sarcoma	0.000316	0.00288	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—PLCG1—sarcoma	0.000316	0.00153	CbGpPWpGaD
Fingolimod—Headache—Vincristine—sarcoma	0.000316	0.00287	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—sarcoma	0.000311	0.00283	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—VEGFC—sarcoma	0.00031	0.0015	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFC—sarcoma	0.00031	0.0015	CbGpPWpGaD
Fingolimod—Headache—Mitoxantrone—sarcoma	0.000307	0.00279	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—sarcoma	0.000303	0.00276	CcSEcCtD
Fingolimod—Eye disorder—Epirubicin—sarcoma	0.000301	0.00274	CcSEcCtD
Fingolimod—Cardiac disorder—Epirubicin—sarcoma	0.000299	0.00272	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—TLE1—sarcoma	0.000295	0.00143	CbGpPWpGaD
Fingolimod—Asthenia—Etoposide—sarcoma	0.000293	0.00266	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—sarcoma	0.000293	0.00266	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—sarcoma	0.000292	0.00266	CcSEcCtD
Fingolimod—Mediastinal disorder—Epirubicin—sarcoma	0.00029	0.00264	CcSEcCtD
Fingolimod—Pruritus—Etoposide—sarcoma	0.000289	0.00262	CcSEcCtD
Fingolimod—Alopecia—Epirubicin—sarcoma	0.000285	0.00259	CcSEcCtD
Fingolimod—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000284	0.00138	CbGpPWpGaD
Fingolimod—Mental disorder—Epirubicin—sarcoma	0.000282	0.00256	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—VEGFC—sarcoma	0.000282	0.00137	CbGpPWpGaD
Fingolimod—Diarrhoea—Etoposide—sarcoma	0.000279	0.00254	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—sarcoma	0.000278	0.00253	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—sarcoma	0.000277	0.00251	CcSEcCtD
Fingolimod—SPHK1—Metabolism—ENO2—sarcoma	0.000276	0.00134	CbGpPWpGaD
Fingolimod—CYP2E1—Tryptophan metabolism—MDM2—sarcoma	0.000275	0.00133	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—HBA1—sarcoma	0.000274	0.00133	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—PLCG1—sarcoma	0.000273	0.00132	CbGpPWpGaD
Fingolimod—Back pain—Epirubicin—sarcoma	0.000271	0.00246	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—sarcoma	0.00027	0.00246	CcSEcCtD
Fingolimod—Dizziness—Etoposide—sarcoma	0.00027	0.00245	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—sarcoma	0.000269	0.00244	CcSEcCtD
Fingolimod—Vision blurred—Epirubicin—sarcoma	0.000264	0.0024	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—sarcoma	0.000263	0.00239	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—sarcoma	0.000261	0.00237	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—FLT1—sarcoma	0.000258	0.00125	CbGpPWpGaD
Fingolimod—Headache—Etoposide—sarcoma	0.000256	0.00232	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—PLCG1—sarcoma	0.000253	0.00123	CbGpPWpGaD
Fingolimod—Leukopenia—Epirubicin—sarcoma	0.000251	0.00228	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—sarcoma	0.000251	0.00228	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—VEGFC—sarcoma	0.000249	0.00121	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—FLT1—sarcoma	0.000248	0.0012	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—FLT1—sarcoma	0.000248	0.0012	CbGpPWpGaD
Fingolimod—Palpitations—Epirubicin—sarcoma	0.000248	0.00225	CcSEcCtD
Fingolimod—Cough—Epirubicin—sarcoma	0.000245	0.00222	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—sarcoma	0.000244	0.00222	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—PLCG1—sarcoma	0.000244	0.00118	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PLCG1—sarcoma	0.000244	0.00118	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCR4—sarcoma	0.000243	0.00118	CbGpPWpGaD
Fingolimod—Hypertension—Epirubicin—sarcoma	0.000242	0.0022	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—ATF1—sarcoma	0.00024	0.00117	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000237	0.00215	CcSEcCtD
Fingolimod—SPHK1—Metabolism—PLCG1—sarcoma	0.000234	0.00114	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCR4—sarcoma	0.000234	0.00114	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCR4—sarcoma	0.000234	0.00114	CbGpPWpGaD
Fingolimod—Leukopenia—Doxorubicin—sarcoma	0.000232	0.00211	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—ATF1—sarcoma	0.000231	0.00112	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—ATF1—sarcoma	0.000231	0.00112	CbGpPWpGaD
Fingolimod—Palpitations—Doxorubicin—sarcoma	0.000229	0.00208	CcSEcCtD
Fingolimod—Infection—Epirubicin—sarcoma	0.000227	0.00207	CcSEcCtD
Fingolimod—Cough—Doxorubicin—sarcoma	0.000226	0.00206	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—FLT1—sarcoma	0.000225	0.00109	CbGpPWpGaD
Fingolimod—Nervous system disorder—Epirubicin—sarcoma	0.000224	0.00204	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—sarcoma	0.000224	0.00204	CcSEcCtD
Fingolimod—Skin disorder—Epirubicin—sarcoma	0.000222	0.00202	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—PLCG1—sarcoma	0.000221	0.00107	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CREB1—sarcoma	0.000221	0.00107	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000219	0.00199	CcSEcCtD
Fingolimod—SPHK1—Metabolism of proteins—MMP2—sarcoma	0.000218	0.00106	CbGpPWpGaD
Fingolimod—Hypotension—Epirubicin—sarcoma	0.000214	0.00194	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CXCR4—sarcoma	0.000213	0.00103	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CREB1—sarcoma	0.000212	0.00103	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CREB1—sarcoma	0.000212	0.00103	CbGpPWpGaD
Fingolimod—Infection—Doxorubicin—sarcoma	0.00021	0.00191	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—ATF1—sarcoma	0.00021	0.00102	CbGpPWpGaD
Fingolimod—Nervous system disorder—Doxorubicin—sarcoma	0.000208	0.00189	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—sarcoma	0.000206	0.00187	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—sarcoma	0.000205	0.00187	CcSEcCtD
Fingolimod—Dyspnoea—Epirubicin—sarcoma	0.000204	0.00185	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—FLT1—sarcoma	0.000199	0.000967	CbGpPWpGaD
Fingolimod—Hypotension—Doxorubicin—sarcoma	0.000198	0.0018	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—sarcoma	0.000198	0.0018	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—sarcoma	0.000197	0.00179	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—PLCG1—sarcoma	0.000196	0.00095	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CREB1—sarcoma	0.000193	0.000935	CbGpPWpGaD
Fingolimod—Paraesthesia—Doxorubicin—sarcoma	0.00019	0.00173	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—sarcoma	0.000189	0.00172	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—IGF1R—sarcoma	0.000189	0.000916	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCR4—sarcoma	0.000188	0.000913	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ATF1—sarcoma	0.000186	0.000903	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000183	0.00166	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—sarcoma	0.000182	0.00166	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—IGF1R—sarcoma	0.000182	0.000881	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IGF1R—sarcoma	0.000182	0.000881	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—FOXO1—sarcoma	0.00018	0.000872	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—IL2—sarcoma	0.00018	0.000871	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PDGFRB—sarcoma	0.000179	0.00087	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—PDGFRA—sarcoma	0.000176	0.000857	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—FOXO1—sarcoma	0.000173	0.000839	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—FOXO1—sarcoma	0.000173	0.000839	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—IL2—sarcoma	0.000173	0.000839	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—IL2—sarcoma	0.000173	0.000839	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PDGFRB—sarcoma	0.000173	0.000838	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PDGFRB—sarcoma	0.000173	0.000838	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—PDGFRA—sarcoma	0.00017	0.000824	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—PDGFRA—sarcoma	0.00017	0.000824	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—CTNNB1—sarcoma	0.000167	0.00081	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IGF1R—sarcoma	0.000165	0.0008	CbGpPWpGaD
Fingolimod—Asthenia—Epirubicin—sarcoma	0.000164	0.00149	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—IL2—sarcoma	0.000163	0.000791	CbGpPWpGaD
Fingolimod—Pruritus—Epirubicin—sarcoma	0.000162	0.00147	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—FOXO1—sarcoma	0.000157	0.000762	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL2—sarcoma	0.000157	0.000762	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL2—sarcoma	0.000157	0.000762	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—IL2—sarcoma	0.000157	0.000761	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PDGFRB—sarcoma	0.000157	0.00076	CbGpPWpGaD
Fingolimod—Diarrhoea—Epirubicin—sarcoma	0.000157	0.00142	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—PDGFRA—sarcoma	0.000154	0.000749	CbGpPWpGaD
Fingolimod—Asthenia—Doxorubicin—sarcoma	0.000152	0.00138	CcSEcCtD
Fingolimod—Dizziness—Epirubicin—sarcoma	0.000151	0.00138	CcSEcCtD
Fingolimod—Pruritus—Doxorubicin—sarcoma	0.00015	0.00136	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—KDR—sarcoma	0.000149	0.000721	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IGF1R—sarcoma	0.000146	0.000708	CbGpPWpGaD
Fingolimod—Diarrhoea—Doxorubicin—sarcoma	0.000145	0.00132	CcSEcCtD
Fingolimod—Headache—Epirubicin—sarcoma	0.000143	0.0013	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—KDR—sarcoma	0.000143	0.000694	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KDR—sarcoma	0.000143	0.000694	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL2—sarcoma	0.000142	0.000692	CbGpPWpGaD
Fingolimod—Dizziness—Doxorubicin—sarcoma	0.00014	0.00127	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—FOXO1—sarcoma	0.000139	0.000674	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PDGFRB—sarcoma	0.000139	0.000673	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KIT—sarcoma	0.000137	0.000664	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—NRAS—sarcoma	0.000137	0.000664	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PDGFRA—sarcoma	0.000137	0.000663	CbGpPWpGaD
Fingolimod—Headache—Doxorubicin—sarcoma	0.000133	0.00121	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—KIT—sarcoma	0.000132	0.000639	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KIT—sarcoma	0.000132	0.000639	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—NRAS—sarcoma	0.000132	0.000639	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—NRAS—sarcoma	0.000132	0.000639	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CREB1—sarcoma	0.00013	0.000632	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KDR—sarcoma	0.00013	0.00063	CbGpPWpGaD
Fingolimod—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.000128	0.000619	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CREB1—sarcoma	0.000125	0.000609	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CREB1—sarcoma	0.000125	0.000609	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—EGFR—sarcoma	0.000125	0.000605	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—EGFR—sarcoma	0.00012	0.000582	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—EGFR—sarcoma	0.00012	0.000582	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KIT—sarcoma	0.00012	0.00058	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—NRAS—sarcoma	0.00012	0.00058	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—KRAS—sarcoma	0.000118	0.000572	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KDR—sarcoma	0.000115	0.000558	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CREB1—sarcoma	0.000114	0.000553	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—KRAS—sarcoma	0.000113	0.00055	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—KRAS—sarcoma	0.000113	0.00055	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—EGFR—sarcoma	0.000109	0.000529	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MDM2—sarcoma	0.000108	0.000523	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KIT—sarcoma	0.000106	0.000514	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MDM2—sarcoma	0.000104	0.000503	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MDM2—sarcoma	0.000104	0.000503	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—KRAS—sarcoma	0.000103	0.0005	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CREB1—sarcoma	0.000101	0.000489	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—HRAS—sarcoma	0.0001	0.000486	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—HRAS—sarcoma	9.64e-05	0.000468	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—HRAS—sarcoma	9.64e-05	0.000468	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL2—sarcoma	9.63e-05	0.000467	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MDM2—sarcoma	9.42e-05	0.000457	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCND1—sarcoma	9.39e-05	0.000456	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—JUN—sarcoma	9.37e-05	0.000455	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CTNNB1—sarcoma	9.3e-05	0.000451	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL2—sarcoma	9.27e-05	0.00045	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL2—sarcoma	9.27e-05	0.00045	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCND1—sarcoma	9.04e-05	0.000439	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCND1—sarcoma	9.04e-05	0.000439	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—JUN—sarcoma	9.02e-05	0.000438	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—JUN—sarcoma	9.02e-05	0.000438	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CTNNB1—sarcoma	8.95e-05	0.000434	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CTNNB1—sarcoma	8.95e-05	0.000434	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—HRAS—sarcoma	8.75e-05	0.000425	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL2—sarcoma	8.42e-05	0.000408	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—SRC—sarcoma	8.4e-05	0.000408	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MDM2—sarcoma	8.34e-05	0.000405	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCND1—sarcoma	8.21e-05	0.000398	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—JUN—sarcoma	8.19e-05	0.000397	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—VEGFA—sarcoma	8.18e-05	0.000397	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CTNNB1—sarcoma	8.13e-05	0.000394	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—SRC—sarcoma	8.09e-05	0.000393	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—SRC—sarcoma	8.09e-05	0.000393	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—NRAS—sarcoma	8.08e-05	0.000392	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—VEGFA—sarcoma	7.88e-05	0.000382	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—VEGFA—sarcoma	7.88e-05	0.000382	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—NRAS—sarcoma	7.78e-05	0.000378	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—NRAS—sarcoma	7.78e-05	0.000378	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—MYC—sarcoma	7.53e-05	0.000365	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2—sarcoma	7.45e-05	0.000362	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—EGFR—sarcoma	7.37e-05	0.000357	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—SRC—sarcoma	7.34e-05	0.000356	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCND1—sarcoma	7.26e-05	0.000352	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—MYC—sarcoma	7.25e-05	0.000352	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—MYC—sarcoma	7.25e-05	0.000352	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—JUN—sarcoma	7.25e-05	0.000352	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CTNNB1—sarcoma	7.19e-05	0.000349	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—VEGFA—sarcoma	7.15e-05	0.000347	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—EGFR—sarcoma	7.09e-05	0.000344	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—EGFR—sarcoma	7.09e-05	0.000344	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—NRAS—sarcoma	7.07e-05	0.000343	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—KRAS—sarcoma	6.96e-05	0.000338	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—KRAS—sarcoma	6.7e-05	0.000325	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—KRAS—sarcoma	6.7e-05	0.000325	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—MYC—sarcoma	6.58e-05	0.000319	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—SRC—sarcoma	6.5e-05	0.000315	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—EGFR—sarcoma	6.44e-05	0.000312	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—VEGFA—sarcoma	6.33e-05	0.000307	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—NRAS—sarcoma	6.25e-05	0.000303	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—TP53—sarcoma	6.18e-05	0.0003	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—KRAS—sarcoma	6.08e-05	0.000295	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—TP53—sarcoma	5.95e-05	0.000289	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—TP53—sarcoma	5.95e-05	0.000289	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—HRAS—sarcoma	5.91e-05	0.000287	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—MYC—sarcoma	5.83e-05	0.000283	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—sarcoma	5.7e-05	0.000276	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—HRAS—sarcoma	5.69e-05	0.000276	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—HRAS—sarcoma	5.69e-05	0.000276	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—sarcoma	5.41e-05	0.000262	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—sarcoma	5.38e-05	0.000261	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—HRAS—sarcoma	5.17e-05	0.000251	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—sarcoma	4.78e-05	0.000232	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—HRAS—sarcoma	4.57e-05	0.000222	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ENO2—sarcoma	4.53e-05	0.00022	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HBA1—sarcoma	4.5e-05	0.000218	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLCG1—sarcoma	3.84e-05	0.000187	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ENO2—sarcoma	3.21e-05	0.000156	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HBA1—sarcoma	3.19e-05	0.000155	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLCG1—sarcoma	2.73e-05	0.000132	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ENO2—sarcoma	2.1e-05	0.000102	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HBA1—sarcoma	2.09e-05	0.000101	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLCG1—sarcoma	1.78e-05	8.66e-05	CbGpPWpGaD
